I’m excited to share a more detailed look into my professional journey and the work I’ve been fortunate to lead at the intersection of AI, data science, and drug discovery. Over the years, I’ve focused on building data-driven strategies and platforms that help translate complex biological data into meaningful therapeutic impact. I’m grateful for the opportunity to collaborate with incredible teams and contribute to innovation in biotech. Here is my biography.

I’m excited to share a comprehensive look at my professional journey across clinical medicine, translational science, biotechnology leadership, and the evolving landscape of precision and AI-enabled drug development. Over the past two decades, I’ve been fortunate to work with extraordinary teams, lead high-impact programs, and contribute to the growth of organizations committed to improving patient lives. Here is my biography.

After decades of leadership in pharmaceutical R&D, I’m excited to share a detailed look at my career journey—from drug discovery to biomarker development, strategic consulting, and beyond. I’ve been fortunate to work alongside exceptional teams and contribute to the development of transformative therapies. Here is my biography.

Dr. Heather E. Stefanski, MD, PhD, is a leading authority in pediatric hematology, stem cell transplantation, and cell therapy innovation. As Executive Vice President of CIBMTR and Clinical Services at the National Marrow Donor Program (NMDP), she drives national and global initiatives focused on donor safety, transplant access, and cellular therapy advancement. With over 65 peer-reviewed publications and multiple patents, Dr. Stefanski blends clinical excellence with groundbreaking research to improve outcomes for patients worldwide. She serves in key leadership roles across the WMDA, ASH, and ASTCT, and is recognized for her visionary contributions to donor health and translational medicine.

I'm honored to share a detailed look into my professional journey as a cardiovascular physician, academic leader, and healthcare strategist. Over the past 17 years, I’ve had the privilege of shaping programs, launching international initiatives, and integrating AI and precision medicine into patient care. I'm passionate about driving systemic change in healthcare and ensuring that innovation serves real people, in real time. Here is my biography.

As a physician-scientist and biotech executive, I have dedicated my career to bridging the gap between groundbreaking medical research and commercial success. From securing multimillion-dollar funding to leading strategic M&A deals, my passion lies in driving healthcare innovation that delivers real-world impact. Here is my biography.

Matthew Smollin, PharmD, is an accomplished leader in medical affairs and clinical innovation with over 15 years of clinical experience and a decade of industry expertise spanning clinical research, regulatory strategy, and team leadership. As Vice President of Medical Affairs at Karius, Inc., he directs medical and scientific strategies, guiding breakthrough advancements in molecular diagnostics while navigating complex FDA and Medicare regulatory processes. Throughout his career, he has successfully built and managed high-performing teams, fostered strong relationships with key opinion leaders, and played a pivotal role in clinical trial design, publication strategy, and scientific engagement. A respected speaker and thought leader, Dr. Smollin’s expertise in infectious disease diagnostics and next-generation sequencing has shaped industry best practices and advanced clinical innovation. His dedication to scientific excellence, strategic vision, and ability to translate complex medical insights into impactful solutions make him a driving force in the evolution of precision medicine and diagnostic technologies.

Excited to share my professional journey in NGS cancer diagnostics, biotech, and healthcare innovation! With over 20 years of experience spanning product management, AI-driven automation, clinical trials, and regulatory compliance, I have led multi-billion-dollar product launches and driven transformative advancements in precision medicine and oncology. My expertise in agile methodologies, strategic planning, and cross-functional leadership has enabled me to bridge science and business for impactful solutions. Here is my biography.

I'm excited to share my journey and experiences in oncology, cancer research, and precision medicine. Over the past 32 years, I’ve had the privilege of founding and leading institutions dedicated to advancing cancer care and improving patient outcomes through innovative research and clinical trials. From my work at the Kentucky Cancer Group to my time as Director of Precision Medicine at Norton Cancer Institute, I’ve focused on integrating cutting-edge therapies and a compassionate approach to oncology. Check out my executive biography to learn more about my work and how I'm committed to pushing the boundaries of cancer care through leadership and collaboration.